By 2030, OSD Contract Manufacturing Will Be $54.7 Billion

As per insights acquired from COVID-19 pandemic, outsourcing production of oral solids will have a huge impact on contract manufacturing in the next 10 years.

Indian Biotech Regulatory Processes Must Be Ramped Up

Three ministries in India control the entire biotech sector, and the ineffective communication and unnecessary steps cause the regulatory procedures to lag.

FDA Expanding Patient Participation In Drug Development

FDA is spotlighting how the Patient-Focused Drug Development programme has allowed patient groups to engage in creating, evaluating, and licensing new drugs.

Junk DNA Could Be The Key To Understanding Neuro Ailments

As non-coding DNA is linked to neurological illnesses like Alzheimers and motor neurone disease, Lincoln and Sheffield are exploring how DNA can be restored.

Developing a Systematic Quality Approach for Injectable Drug Products

What’s the optimal approach to creating such an end-to-end system? Oliver Kurz, Vice President Quality Assurance at Vetter Pharma-Fertigung GmbH & Co. KG, shares his insights.

How ‘First-Time Right’ Formulations Can Help Address the Challenge of Affordable Medicines

How can one develop and distribute safe, innovative medicines faster and cheaper than ever before while still operating within a sustainable business model?